In a previous report we described MAPK and AKT/mTOR pathway activations in a series of skin melanomas, where an association between BRAF mutation and high mTOR pathway activation was observed (Populo et al., 2011a). The gene discussed is MTOR; the disease is cutaneous melanoma.